Nature's Sunshine Products, Inc. (NATR)
NASDAQConsumer StaplesPackaged FoodsSnapshot 2026-09-04
NASDAQConsumer StaplesPackaged FoodsSnapshot 2026-09-04
QuarterlyIQ Insights · NATR
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Executive Vice President, Chief Financial Officer — Ms. Ruth Perkins: Appointment of a new CFO with extensive finance leadership experience.
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
Chief Financial Officer — L. Shane Jones: The CFO is resigning, which could signal a significant change in the company's financial leadership.
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
The filing describes the approval of a new stock incentive plan, which is not related to any management change.
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
Compensatory arrangements and salary increases for certain officers.
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
President and Chief Executive Officer — Terrence O. Moorehead: Mr. Moorehead decided to step down as President, CEO, and Board member.
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. As previously disclosed, on August 25, 2014, Nature’s Sunshine Products, Inc. (the “Company”), completed a transaction with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”), which created two joint ventures each owned 80% by the Company and 20% by Fosun Industrial Co., Ltd., (“Fosun Industrial”). a wholly owned subsidiary of Fosun Pharma. The joint ventures, known as Nature’s Sunshine Hong Kong Limited (the “Hong Kong Joint Venture”)…
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. On June 25, 2025, Nature’s Sunshine Products, Inc., a Utah corporation (the “Company”), entered into an underwriting agreement (the “Underwriting Agreement”) with D.A. Davidson & Co. as representative of the several underwriters listed in Schedule A thereto (the “Underwriters”), and Fosun Pharma USA, Inc. (the “Selling Stockholder”), relating to an underwritten secondary public offering of 2,854,607 shares of common stock of the Company, no par valu…
President and CEO — Terrence O. Moorehead: Terrence O. Moorehead decided to step down as an officer and resign as a director of the Company.
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
The filing details compensatory arrangements, specifically salary increases for certain officers.
Director — Mr. Richard D. Moss: Mr. Richard D. Moss decided not to stand for re-election at the upcoming annual shareholder meeting.
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
Director — Mr. Steven J. Fasching: The company appointed a new independent director to its board.
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
The company approved salary and incentive increases for certain officers.
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.